Evidence map›Paper›PMID 38640168›Full record

ArticleJournal of Parkinson's disease2024

Identifying New Subtypes of Multiple System Atrophy Using Cluster Analysis.

Xiaobing Li, Jing Bai, Xin Guo, Yaqian Mu, Zhengli Di, Gejuan Zhang, Bo Wang, Yun Zhang, Xinyao Liu, Yan Shi and 4 more

Abstract read
In one paragraph

Article in Journal of Parkinson's disease, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Xiaobing LiDepartment of Neurology, Xijing Hospital, Air Force Medical University, Xi'an, Shaanxi, China.
Jing BaiDepartment of Neurology, Xijing Hospital, Air Force Medical University, Xi'an, Shaanxi, China.
Xin GuoDepartment of Neurology, Xijing Hospital, Air Force Medical University, Xi'an, Shaanxi, China.
Yaqian MuDepartment of Neurology, Xijing Hospital, Air Force Medical University, Xi'an, Shaanxi, China.
Zhengli DiDepartment of Neurology, Xi'an Central Hospital, Xi'an, Shaanxi, China.
Gejuan ZhangDepartment of Neurology, Xi'an Third Hospital, Xi'an, Shaanxi, China.
Bo WangDepartment of Epidemiology, Air Force Medical University, School of Public Health, Xi'an, Shaanxi, China.
Yun ZhangDepartment of Neurology, Xi'an Ninth Hospital, Xi'an, Shaanxi, China.
Xinyao LiuDepartment of Neurology, Xijing Hospital, Air Force Medical University, Xi'an, Shaanxi, China.
Yan ShiDepartment of Neurology, Xijing Hospital, Air Force Medical University, Xi'an, Shaanxi, China.
Shinuan LinGYENNO Science Co., Ltd., Shenzhen, Guangdong, China.
Linyu WuGYENNO Science Co., Ltd., Shenzhen, Guangdong, China.
Ya BaiDepartment of Neurology, Xijing Hospital, Air Force Medical University, Xi'an, Shaanxi, China.
Xuedong LiuDepartment of Neurology, Xijing Hospital, Air Force Medical University, Xi'an, Shaanxi, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Multiple system atrophy (MSA) is a disease with diverse symptoms and the commonly used classifications, MSA-P and MSA-C, do not cover all the different symptoms seen in MSA patients. Additionally, these classifications do not provide information about how the disease progresses over time or the expected outcome for patients. Objective: To explore clinical subtypes of MSA with a natural disease course through a data-driven approach to assist in the diagnosis and treatment of MSA. Methods: We followed 122 cases of MSA collected from 3 hospitals for 3 years. Demographic characteristics, age of onset, clinical signs, scale assessment scores, and auxiliary examination were collected. Age at onset; time from onset to assisted ambulation; and UMSARS I, II, and IV, COMPASS-31, ICARS, and UPDRS III scores were selected as clustering elements. K-means, partitioning around medoids, and self-organizing maps were used to analyze the clusters. Results: The results of all three clustering methods supported the classification of three MSA subtypes: The aggressive progression subtype (MSA-AP), characterized by mid-to-late onset, rapid progression and severe clinical symptoms; the typical subtype (MSA-T), characterized by mid-to-late onset, moderate progression and moderate severity of clinical symptoms; and the early-onset slow progression subtype (MSA-ESP), characterized by early-to-mid onset, slow progression and mild clinical symptoms. Conclusions: We divided MSA into three subtypes and summarized the characteristics of each subtype. According to the clustering results, MSA patients were divided into three completely different types according to the severity of symptoms, the speed of disease progression, and the age of onset.

Indexed as

Disease ProgressionMultiple System AtrophyAgedAge of OnsetCluster AnalysisFemaleHumansMaleMiddle AgedSeverity of Illness Indexautonomic nervous system diseasescluster analysisgait ataxiaMultiple system atrophyparkinsonian disorders

Identifiers

PMID38640168
PMCPMC11191464

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.